NCT04854837View on ClinicalTrials.gov

Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Covid19End Stage Renal Failure on Dialysis
Interventions
DRUG

Remdesivir

Remdesivir treatment

Trial Locations (1)

1083

Semmelweis University - Department of Internal Medicine and Oncology, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER